Sarepta Therapeutics, Inc. SEC filings SRPT
Sarepta Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Mar 31, 2011. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 4, 2026 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Jun 5, 2025 |
| DEF 14A | Proxy statement | Apr 24, 2024 | Jun 6, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2024 | — |
| DEFA14A | Additional proxy material | Apr 24, 2023 | — |
| DEF 14A | Proxy statement | Apr 24, 2023 | — |
| DEF 14A | Proxy statement | Apr 25, 2022 | Jun 2, 2022 |
| DEFA14A | Additional proxy material | Apr 20, 2021 | — |
| DEF 14A | Proxy statement | Apr 20, 2021 | Jun 3, 2021 |
| DEFA14A | Additional proxy material | Apr 21, 2020 | — |
| DEF 14A | Proxy statement | Apr 21, 2020 | Jun 4, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 8, 2020 | Jun 4, 2020 |
| DEFA14A | Additional proxy material | Apr 26, 2019 | — |
| DEF 14A | Proxy statement | Apr 26, 2019 | Jun 6, 2019 |
| DEFA14A | Additional proxy material | Apr 26, 2018 | — |
| DEF 14A | Proxy statement | Apr 26, 2018 | Jun 6, 2018 |
| DEFA14A | Additional proxy material | Apr 27, 2017 | — |
| DEF 14A | Proxy statement | Apr 27, 2017 | Jun 6, 2017 |
| DEF 14A | Proxy statement | May 31, 2016 | Jun 27, 2016 |
| PRE 14A | Preliminary proxy statement | May 16, 2016 | Jun 27, 2016 |
| DEFA14A | Additional proxy material | May 19, 2015 | — |
| DEF 14A | Proxy statement | Apr 30, 2015 | Jun 2, 2015 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2015 | Apr 20, 2015 |
| DEF 14A | Proxy statement | Apr 30, 2014 | Jun 3, 2014 |
| DEF 14A | Proxy statement | Apr 30, 2013 | Jun 4, 2013 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2013 | Jun 4, 2013 |
| DEF 14A | Proxy statement | Jun 13, 2012 | Jul 10, 2012 |
| PRE 14A | Preliminary proxy statement | Jun 1, 2012 | Jul 10, 2012 |
| DEF 14A | Proxy statement | May 20, 2011 | Jun 13, 2011 |
| PRE 14A | Preliminary proxy statement | May 6, 2011 | Jun 13, 2011 |
Showing 32 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SRPT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 873303
- Former names
- Sarepta Therapeutics, Inc. (until Sep 23, 2026); AVI BIOPHARMA INC (until Jul 12, 2012); ANTIVIRALS INC (until May 12, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.